Marinus Pharma

$10.80 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Marinus Pharma

Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings.

Stock Analysis

last close $10.54
1-mo return 1.1%
3-mo return -4.4%
avg daily vol. 109.36T
52-week high 20.04
52-week low 9.1
market cap. $407M
forward pe -
annual div. -
roe -115%
ltg forecast -
dividend yield -
annual rev. $15M
inst own. 89.5%

Subscribe now for daily local and international financial news